These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 30922343)
1. Proposed revision of the 8th edition AJCC clinical staging system for esophageal squamous cell cancer treated with definitive chemo-IMRT based on CT imaging. Chen M; Li X; Chen Y; Liu P; Chen Z; Shen M; Liu X; Lin Y; Yang R; Ni W; Zhou X; Zhang L; Tian Y; Chen J; Fu L Radiat Oncol; 2019 Mar; 14(1):54. PubMed ID: 30922343 [TBL] [Abstract][Full Text] [Related]
2. A new clinical staging system for esophageal cancer to predict survival after definitive chemoradiation or radiotherapy. Chen J; Lin Y; Cai W; Su T; Wang B; Li J; Wu J; Pan J; Chen C Dis Esophagus; 2018 Nov; 31(11):. PubMed ID: 29961898 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers. Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648 [TBL] [Abstract][Full Text] [Related]
4. Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy. Inada M; Nishimura Y; Ishikawa K; Nakamatsu K; Wada Y; Uehara T; Fukuda K; Anami S; Doi H; Kanamori S Esophagus; 2019 Oct; 16(4):371-376. PubMed ID: 31111308 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy. Nomura M; Shitara K; Kodaira T; Hatooka S; Mizota A; Kondoh C; Yokota T; Takahari D; Ura T; Muro K Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):946-52. PubMed ID: 21362578 [TBL] [Abstract][Full Text] [Related]
6. Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancer. Hu K; Kang N; Liu Y; Guo D; Jing W; Lu J; Tan T; Lv C; Deng Y; Long J; Wang R; Yu J Cancer Sci; 2019 Feb; 110(2):717-725. PubMed ID: 30467921 [TBL] [Abstract][Full Text] [Related]
7. Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement. Chung TR; Kim JH; Lee IJ; Cho Y; Kim JW; Lee CG; Jung DH; Park JJ; Youn YH; Park H Dig Liver Dis; 2019 Nov; 51(11):1610-1616. PubMed ID: 31175014 [TBL] [Abstract][Full Text] [Related]
8. The impact of the nodal status on the overall survival of non-surgical patients with esophageal squamous cell carcinoma. Zhao Z; Zhang Y; Wang P; Wang X; Li M Radiat Oncol; 2019 Sep; 14(1):161. PubMed ID: 31481064 [TBL] [Abstract][Full Text] [Related]
9. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma. Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544 [TBL] [Abstract][Full Text] [Related]
10. Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy. Liu G; Yang Z; Li T; Yang L; Zheng X; Cai L J Cancer Res Ther; 2017; 13(5):748-755. PubMed ID: 29237898 [TBL] [Abstract][Full Text] [Related]
11. Lymph node ratio-based staging system for esophageal squamous cell carcinoma. Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998 [TBL] [Abstract][Full Text] [Related]
12. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification. Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909 [TBL] [Abstract][Full Text] [Related]
13. [Exploration of the classification of gross tumor volume and pathological staging of esophageal carcinoma]. Xu Q; Zhu SC; Liu ZK; Cao YK; Song CL; Li YM; Wang SJ Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):432-5. PubMed ID: 20819484 [TBL] [Abstract][Full Text] [Related]
14. Validation of the 8 van Gysen K; Stevens M; Guo L; Jayamanne D; Veivers D; Wignall A; Pang L; Guminski A; Lee A; Hruby G; Macleod P; Taylor A; Eade T BMC Cancer; 2019 Jul; 19(1):674. PubMed ID: 31288767 [TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma. Chen J; Su T; Lin Y; Wang B; Li J; Pan J; Chen C Clin Transl Oncol; 2018 Mar; 20(3):411-419. PubMed ID: 28779422 [TBL] [Abstract][Full Text] [Related]
16. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy. Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584 [TBL] [Abstract][Full Text] [Related]
17. Radiation field size and dose determine oncologic outcome in esophageal cancer. Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673 [TBL] [Abstract][Full Text] [Related]
18. Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT. Studer G; Glanzmann C Oral Oncol; 2013 Mar; 49(3):269-76. PubMed ID: 23089460 [TBL] [Abstract][Full Text] [Related]
19. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma. Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635 [TBL] [Abstract][Full Text] [Related]
20. [Relationship of gross tumor volume with lymph node metastasis and prognosis of esophageal carcinoma]. Xu Q; Liu ZK; Cao YK; Li YM; Zhu SC Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):684-7. PubMed ID: 23159082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]